Pulmonx Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Pulmonx Corporation income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue83.7968.6853.6648.4232.73
Cost of Revenue21.7917.9213.8012.7911.53
Gross Profit62.0050.7539.8735.6321.20
Operating Expenses
Research & Development17.5718.0815.4013.067.46
Selling, General & Administrative102.1494.6183.1169.8746.07
Operating Expenses119.71112.6998.5082.9353.53
Operating Income-57.70-61.94-58.64-47.30-32.33
Other Income/Expense
Interest Income5.065.571.530.400.21
Interest Expense3.51-3.231.070.83-3.18
Other Income/Expense1.810.13-0.40-0.593.18
Income
Income Before Tax-55.89-60.27-58.57-48.32-32.02
Income Tax Expense0.500.570.350.340.21
Net Income-56.39-60.84-58.92-48.66-32.23
Net Income - Continuous Operations-56.39-60.84-58.92-48.660.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-50.79-60.39-55.99-46.62-31.85
EBIT-55.89-61.94-57.50-47.49-32.33
Depreciation & Amortization1.591.551.400.870.48
Earnings Per Share
Basic EPS-1.00-2.00-2.00-1.00-3.00
Diluted EPS-1.00-2.00-2.00-1.00-3.00
Basic Shares Outstanding39.1137.9737.1036.1310.18
Diluted Shares Outstanding39.1137.9737.1036.1310.18